NCT02805348View on ClinicalTrials.gov

Post-marketing Surveillance of Bixalomer in Patients With Pre-dialysis Chronic Kidney Disease

CompletedOBSERVATIONAL
Enrollment

144

Participants

Timeline

Start Date

June 1, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Chronic Kidney Disease
Interventions
DRUG

Bixalomer

Oral

Trial Locations (14)

Unknown

Site JP00006, Aichi

Site JP00010, Ehime

Site JP00012, Fukuoka

Site JP00004, Gifu

Site JP00001, Ibaraki

Site JP00009, Kagawa

Site JP00003, Kanagawa

Site JP00011, Kochi

Site JP00014, Kumamoto

Site JP00013, Nagasaki

Site JP00007, Osaka

Site JP00005, Shizuoka

Site JP00002, Tochigi

Site JP00008, Wakayama

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT02805348 - Post-marketing Surveillance of Bixalomer in Patients With Pre-dialysis Chronic Kidney Disease | Biotech Hunter | Biotech Hunter